Baudax Bio

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Baudax Bio sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 9 completed top decile by trial count

Baudax Bio: 11 sponsored US clinical trials, none currently recruiting.

Baudax Bio sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 6 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pain, Postoperative, with 3 trials.

Top-decile sponsor footprint

Baudax Bio ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

9 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

11 total, page 1 of 1

COMPLETED Phase 2

Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery

NCT05687253
TERMINATED Phase 4

Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery

NCT05315479
COMPLETED Phase 3

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

NCT03434275
COMPLETED Phase 2

Evaluation of DEX-IN During Outpatient Procedures

NCT03348423
COMPLETED Phase 3

Evaluation of Preoperative N1539 in Colorectal Surgery

NCT03323385
COMPLETED Phase 3

Evaluation of N1539 Following Major Surgery

NCT02720692
COMPLETED Phase 3

Evaluation of N1539 Following Bunionectomy Surgery

NCT02675907
COMPLETED Phase 3

Evaluation of N1539 Following Abdominoplasty Surgery

NCT02678286
COMPLETED Phase 2

Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

NCT02540265
COMPLETED Phase 2

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery

NCT02284243
TERMINATED Phase 2

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

NCT02169336

Phase Distribution

PhaseTrial count
Phase 2 5
Phase 3 5
Phase 4 1

Therapeutic Areas

Pain, Postoperative 3

How the Baudax Bio archive is shaped

11 indexed studies, none listed as recruiting (0% open); 9 completed (82%).

Phase mix: 6 late (III/IV) vs 5 early (I/II) (balanced across stages).

Top condition: Pain, Postoperative (3 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Baudax Bio: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Baudax Bio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Baudax BioAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
Baudax Bio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baudax Bio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Baudax Bio page

11 registered trials is a research-attention snapshot, not an endorsement of Baudax Bio or any single study.

  • None of Baudax Bio's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pain, Postoperative is the condition Baudax Bio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pain, Postoperative trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Baudax Bio pipeline card: 11 registered trials from official public datasets.Report a data error.